Zusammenfassung
Poststroke-Depression (PSD) ist die häufigste psychiatrische Komplikation nach Schlaganfall (bis zu 50%) und ist sowohl für schlaganfallassoziierte Morbidität als auch Mortalität relevant. Vermutlich wird die PSD in der klinischen Praxis zu selten diagnostiziert und häufig nicht adäquat behandelt. Diese Übersichtsarbeit fasst den gegenwärtigen Kenntnisstand zu Epidemiologie, Klinik, Prädisposition und Risikofaktoren, Therapie und Prophylaxe sowie pathophysiologischen Konzepten zusammen.
Summary
Post-stroke depression (PSD) is the most frequent psychiatric complication following ischemic stroke, affecting up to 50% of all such patients. Moreover, PSD is associated with increased morbidity and mortality following ischemic stroke. In clinical practice, PSD is underdiagnosed and many affected patients do not receive adequate treatment. This review article summarizes current knowledge regarding epidemiogy, clinical features, risk factors and predisposition, therapy, and prophylaxis of PSD.
Literatur
Aben I, Verhey F, Strik J et al. (2003) A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry 74(5): 581–585
Alexopoulos GS, Meyers BS, Young RC et al. (1997) ‘Vascular depression‘ hypothesis. Arch Gen Psychiatry 54(10): 915–922
Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25(6): 1099–1104
Astrom M (1996) Generalized anxiety disorder in stroke patients. A 3-year longitudinal study. Stroke 27(2): 270–275
Berg A, Palomaki H, Lehtihalmes M et al. (2003) Poststroke depression: an 18-month follow-up. Stroke 34(1): 138–143
Berton O, McClung CA, Dileone RJ et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762): 864–868
Bhogal SK, Teasell R, Foley N et al. (2005) Heterocyclics and selective serotonin reuptake inhibitors in treatment and prevention of poststroke depression. J Am Geriatr Soc 53(6): 1051–1057
Biran I, Chatterjee A (2003) Depression with anosognosia following a left subcortical stroke. Clin Neurol Neurosurg 105(2): 99–101
Boden-Albala B, Litwak E, Elkind MS et al. (2005) Social isolation and outcomes poststroke. Neurology 64(11): 1888–1892
Bozikas VP, Gold G, Kovari E et al. (2005) Pathological correlates of poststroke depression in elderly patients. Am J Geriatr Psychiatry 13(2): 166–169
Bruce EC, Musselman DL (2005) Depression, alterations of platelet function, and ischemic heart disease. Psychosom Med 67(Suppl 1): S34–S36
Carota A, Berney A, Aybek S et al. (2005) A prospective study of predictors of poststroke depression. Neurology 64: 428–433
Carson AJ, MacHale S, Allen K et al. (2000) Depression after stroke and lesion location: a systematic review. Lancet 356(9224): 122–126
Cassidy EM, Walsh MT, O’Connor R et al. (2003) Platelet surface glycoprotein expression in poststroke depression: a preliminary study. Psychiatry Res 118(2): 175–181
Choi-Kwon S, Han SW, Kwon SU et al. (2006) Fluoxetine treatment in poststroke depression, emotional incontinence and anger proneness. A double-blind, placebo-controlled study. Stroke 37(1): 156–161
Currier MB, Murray GB, Welch CC (1992) Electroconvulsive therapy for poststroke depressed geriatric patients. J Neuropsychiatry Clin Neurosci 4(2): 140–144
Dam H, Pedersen HE, Ahlgren P (1989) Depression among patients with stroke. Acta Psychiatr Scand 80(2): 118–124
Dantendorfer K, Amering M, Prayer D et al. (1996) Treatment of Koro and panic attacks after stroke. Anxiety 2(1): 53–55
Dean CE (2004) Mortality and poststroke depression. Am J Psychiatry 161(8): 1506
Deuschle M, Lederbogen F (2002) Depression und koronare Herzerkrankung: pathogenetische Faktoren vor dem Hintergrund des Stresskonzeptes. Fortschr Neurol Psychiatr 70: 268–275
Dieguez S, Staub F, Bruggimann L et al. (2004) Is poststroke depression a vascular depression? J Neurol Sci 226: 53–58
Endres M, Fan G, Hirt L et al. (2000) Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. J Cereb Blood Flow Metab 20(1): 139–144
Everson SA, Roberts RE, Goldberg DE et al. (1998) Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 158(10): 1133–1138
Fedoroff JP, Starkstein SE, Parikh RM et al. (1991) Are depressive symptoms nonspecific in patients with acute stroke? Am J Psychiatry 148(9): 1172–1176
Ferketich AK, Ferguson JP, Binkley PF (2005) Depressive symptoms and inflammation among heart failure patients. Am Heart J 150(1): 132–136
Folstein MF, Maiberger R, McHugh PR (1977) Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 40(10): 1018–1020
Fruehwald S, Gatterbauer E, Rehak P et al. (2003) Early fluoxetine treatment of poststroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow-up. J Neurol 250(3): 347–351
Gass P, Reichardt HM, Strekalova T et al. (2001) Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety? Physiol Behav 73(5): 811–825
Ghose SS, Williams LS, Swindle RW (2005) Depression and other mental health diagnoses after stroke increase inpatient and outpatient medical utilization three years poststroke. Med Care 43(12): 1259–1264
Hackett ML, Anderson CS (2005) Predictors of depression after stroke: a systematic review of observational studies. Stroke 36(10): 2296–2301
Hackett ML, Anderson CS, House AO (2005) Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 36(5): 1098–1103
Herrmann N, Black SE, Lawrence J et al. (1998) The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke 29(3): 618–624
Hickie I, Scott E, Mitchell P et al. (1995) Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37(3): 151–160
Huff W, Steckel R, Sitzer M (2003) Poststroke depression: risk factors and effects on the course of the stroke. Nervenarzt 74(2): 104–114
Jonas BS, Mussolino ME (2000) Symptoms of depression as a prospective risk factor for stroke. Psychosom Med 62(4): 463–471
Jorge RE, Robinson RG, Arndt S et al. (2003) Mortality and poststroke depression: a placebo-controlled trial of antidepressant. Am J Psychiatry 160(10): 1823–1829
Jorge RE, Robinson RG, Tateno A et al. (2004) Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 55(4): 398–405
Kotila M, Numminen H, Waltimo O et al. (1998) Depression after stroke: results of the FINNSTROKE study. Stroke 29(2): 368–372
Larson SL, Owens PL, Ford D et al. (2001) Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 32(9): 1979–1983
Lesser IM, Boone KB, Mehringer CM et al. (1996) Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 153(10): 1280–1287
Malberg JE, Eisch AJ, Nestler EJ et al. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24): 9104–9110
Maricle RA, Sennhauser S, Burry M (1991) Panic disorder associated with right parahippocampal infarction. J Nerv Ment Dis 179(6): 374–375
Mayo NE, Korner-Bitensky NA, Becker R (1991) Recovery time of independent function poststroke. Am J Phys Med Rehabil 70(1): 5–12
Mimura M, Nakagome K, Hirashima N et al. (2005) Left frontotemporal hyperperfusion in a patient with poststroke mania. Psychiatry Res 139(3): 263–267
Morris PL, Raphael B, Robinson RG (1992) Clinical depression is associated with impaired recovery from stroke. Med J Aust 157(4): 239–242
Morris PL, Robinson RG, Andrzejewski P et al. (1993) Association of depression with 10-year poststroke mortality. Am J Psychiatry 150(1): 124–129
Murray GB, Shea V, Conn DK (1986) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47(5): 258–260
Murray V, von Arbin M, Bartfai A et al. (2005) Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 66(6): 708–716
Nagaratnam N, Wong KK, Patel I (2006) Secondary mania of vascular origin in elderly patients: A report of two clinical cases. Arch Gerontol Geriatr (in press)
Narushima K, Kosier JT, Robinson RG (2002) Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 190(5): 296–303
Narushima K, Kosier JT, Robinson RG (2003) A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 15(4): 422–430
Nestler EJ, Gould E, Manji H et al. (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52(6): 503–528
Neu P, Schlattmann P, Schilling A et al. (2004) Cerebrovascular reactivity in major depression: a pilot study. Psychosom Med 66(1): 6–8
Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15(11): 7539–7547
Niedermaier N, Bohrer E, Schulte K et al. (2004) Prevention of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 65(12): 1619–1623
Nilsson FM, Kessing LV (2004) Increased risk of developing stroke for patients with major affective disorder—a registry study. Eur Arch Psychiatry Clin Neurosci 254(6): 387–391
Nys GM, van Zandvoort MJ, van der Worp HB et al. (2005) Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. J Neurol Sci 228(1): 27–33
Ohira T, Iso H, Satoh S et al. (2001) Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke 32(4): 903–908
Ostir GV, Markides KS, Peek MK et al. (2001) The association between emotional well-being and the incidence of stroke in older adults. Psychosom Med 63(2): 210–215
Palomaki H, Kaste M, Berg A et al. (1999) Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 66(4): 490–494
Paolucci S, Antonucci G, Grasso MG et al. (2001) Poststroke depression, anti-depressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis 12(3): 264–271
Paolucci S, Gandolfo C, Provinciali L et al. (2005) Quantification of the risk of post stroke depression: the Italian multicenter observational study DESTRO. Acta Psychiatr Scand 112(4): 272–278
Paradiso S, Robinson RG (1999) Minor depression after stroke: an initial validation of the DSM-IV construct. Am J Geriatr Psychiatry 7(3): 244–251
Post F (1972) The management and nature of depressive illnesses in late life: a follow-through study. Br J Psychiatry 121(563): 393–404
Rasmussen A, Lunde M, Poulsen DL et al. (2003) A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 44(3): 216–221
Robinson RG (2005) Vascular depression and poststroke depression. Where do we go from here? Am J Geriatr Psychiatry 13(2): 85–87
Santarelli L, Saxe M, Gross C et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634): 805–809
Simons LA, McCallum J, Friedlander Y et al. (1998) Risk factors for ischemic stroke: dubbo study of the elderly. Stroke 29(7): 1341–1346
Singh A, Black SE, Herrmann N et al. (2000) Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke 31(3): 637–644
Sinyor D, Jacques P, Kaloupek DG et al. (1986) Poststroke depression and lesion location. An attempted replication. Brain 109(Pt 3): 537–546
Spencer KA, Tompkins CA, Schulz R (1997) Assessment of depression in patients with brain pathology: the case of stroke. Psychol Bull 122(2): 132–152
Starkstein SE, Fedoroff JP, Price TR et al. (1992) Anosognosia in patients with cerebrovascular lesions. A study of causative factors. Stroke 23(10): 1446–1453
Steffens DC, Conway CR, Dombeck CB et al. (2001) Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. J ECT 17: 45–49
Tang WK, Ungvari GS, Chiu HF et al. (2002) Psychiatric morbidity in first time stroke patients in Hong Kong: a pilot study in a rehabilitation unit. Aust N Z J Psychiatry 36(4): 544–549
Thomas AJ, O’Brien JT, Davis S et al. (2002) Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 59(9): 785–792
Thomas AJ, Perry R, Kalaria RN et al. (2003) Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry 18(1): 7–13
Thomas AJ, Kalaria RN, O’Brien JT (2004) Depression and vascular disease: what is the relationship? J Affect Disord 79(1–3): 81–95
Toso V, Gandolfo C, Paolucci S et al. (2004) Poststroke depression: research methodology of a large multicentre observational study (DESTRO). Neurol Sci 25(3): 138–144
Tupler LA, Krishnan KR, McDonald WM et al. (2002) Anatomic location and laterality of signal hyperintensities in late-life depression. J Psychosom Res 53(2): 665–676
Whyte EM, Mulsant BH (2002) Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 52: 253–264
Wiart L, Petit H, Joseph PA et al. (2000) Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 31(8): 1829–1832
Williams LS (2005) Depression and stroke: cause or consequence? Semin Neurol 25(4): 396–409
Williams LS, Ghose SS, Swindle RW (2004) Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 161(6): 1090–1095
Winter B, Juckel G, Victorov I et al. (2005) Anxious and hyperactive phenotype following brief ischemic episodes in mice. Biol Psychiatry 57(10): 1166–1175
Burvill PW, Johnson GA, Jamrozik KD et al. (1995) Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry 166(3): 320-327
Pohjasvaara T,Leppavuori A, Siira I et al. (1998) Frequency and clinical determinants of poststroke depression. Stroke 29(11): 2311-2317
Kauhanen M, Korpelainen JT, Hiltunen P et al. (1999) Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 30(9): 1875-1880
Astrom M, Adolfsson R, Asplund K (1993) Major depression in stroke patients. A 3-year longitudinal study. Stroke 24(7): 976-982
Interessenkonflikt
Die Forschergruppe „Interdisziplinäre Schlaganfallforschung“ wird von der Volkswagen-Stiftung gefördert (Lichtenberg-Professur, M.E.). Trotz des möglichen Interessenkonfliktes ist der Beitrag unabhängig und produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kronenberg, G., Katchanov, J. & Endres, M. Poststroke-Depression. Nervenarzt 77, 1176–1185 (2006). https://doi.org/10.1007/s00115-006-2130-y
Issue Date:
DOI: https://doi.org/10.1007/s00115-006-2130-y